Belinostat
Especificaciones
414864-00-9Número CAS
111-196-3Número CE
(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamideNombre IUPAC
C15H14N2O4SFórmula química
318.3 g/molPeso molecular
Belinostat; 866323-14-0; PXD101; Beleodaq; PXD-101; PXD 101; (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; NSC726630; PX-105684; NSC-726630; (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; F4H96P17NZ; 2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-; CHEBI:61076; DTXSID60194378; 2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-; N-hydroxy-3-(3-(phenylsulfamoyl)phenyl)prop-2-enamide; 2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-, (2E)-; N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide; (2E)-N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE; belinostatum; (E)-N-hydroxy-3-(3-(phenylsulfamoyl)phenyl)prop-2-enamide; RefChem:56998; DTXCID70116869; L01XX49; 112-468-4; 414864-00-9; Belinostat (PXD101); (E)-N-hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide; N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE; N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide; N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE; MFCD08064035; (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide; PX 105684; (E)-3-[3-(phenylsulfamoyl)phenyl]prop-2-enehydroxamic acid; E-Belinostat; Belinostat [USAN]; Belinostat [USAN:INN]; N-Hydroxy-3-[3-(N-phenylsulfamoyl)phenyl]acrylamide; UNII-F4H96P17NZ; N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-2-PROPENAMIDE; PXD101;PX105684; Beleodaq (TN); (E/Z)-Belinostat; BELINOSTAT [MI]; BELINOSTAT [INN]; Belinostat (USAN/INN); Belinostat (PXD101)?; BELINOSTAT [VANDF]; N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]-2-propenamide; BELINOSTAT [WHO-DD]; N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide; MLS006011091; [(1)(3)C6] Belinostat; SCHEMBL375906; CHEMBL408513; GTPL7496; orb1225090; orb1298864; orb1307324; BELINOSTAT [ORANGE BOOK]; Belinostat(Random Configuration); SCHEMBL29379950; BDBM25150; CHEBI:94531; EX-A180; NCNRHFGMJRPRSK-MDZDMXLPSA-N; (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide.; GLXC-90090; HMS5079G09; PRA86400; Belinostat,PXD101, PX105684; EBC-11342; NSC758774; AKOS025401741; CCG-208758; DB05015; FB76300; FB76301; NSC-758774; NCGC00263155-02; NCGC00263155-05; NCGC00263155-09; NCGC00263155-11; AC-25046; AC-35365; AS-17068; BP-40065; SMR004702879; SY067890; B5888; NS00069313; SW219445-1; T8517; A12508; D08870; EN300-7361191; Q4882925; BRD-K17743125-001-01-9; BRD-K17743125-001-08-4; (E)-N-Hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide; 5OGSinónimos
